153 related articles for article (PubMed ID: 37819449)
1. Infiltrating macrophages amplify doxorubicin-induced cardiac damage: role of catecholamines.
Gambardella J; Santulli G; Fiordelisi A; Cerasuolo FA; Wang X; Prevete N; Sommella E; Avvisato R; Buonaiuto A; Altobelli GG; Rinaldi L; Chiuso F; Feliciello A; Dal Piaz F; Campiglia P; Ciccarelli M; Morisco C; Sadoshima J; Iaccarino G; Sorriento D
Cell Mol Life Sci; 2023 Oct; 80(11):323. PubMed ID: 37819449
[TBL] [Abstract][Full Text] [Related]
2. COX5A Alleviates Doxorubicin-Induced Cardiotoxicity by Suppressing Oxidative Stress, Mitochondrial Dysfunction and Cardiomyocyte Apoptosis.
Zhang P; Lu H; Wu Y; Lu D; Li C; Yang X; Chen Z; Qian J; Ge J
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373547
[TBL] [Abstract][Full Text] [Related]
3. M2b macrophages protect against doxorubicin induced cardiotoxicity via alternating autophagy in cardiomyocytes.
Chen S; Huang Y; Huang S; Zhou Z; Liu K; Pan J; Wu Z
PLoS One; 2023; 18(7):e0288422. PubMed ID: 37498828
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor II receptor-α is a novel stress-inducible contributor to cardiac damage underpinning doxorubicin-induced oxidative stress and perturbed mitochondrial autophagy.
Pandey S; Kuo WW; Shen CY; Yeh YL; Ho TJ; Chen RJ; Chang RL; Pai PY; Viswanadha VP; Huang CY; Huang CY
Am J Physiol Cell Physiol; 2019 Aug; 317(2):C235-C243. PubMed ID: 31116582
[TBL] [Abstract][Full Text] [Related]
5. SESN2 protects against doxorubicin-induced cardiomyopathy via rescuing mitophagy and improving mitochondrial function.
Wang P; Wang L; Lu J; Hu Y; Wang Q; Li Z; Cai S; Liang L; Guo K; Xie J; Wang J; Lan R; Shen J; Liu P
J Mol Cell Cardiol; 2019 Aug; 133():125-137. PubMed ID: 31199952
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-12p35 Knock Out Aggravates Doxorubicin-Induced Cardiac Injury and Dysfunction by Aggravating the Inflammatory Response, Oxidative Stress, Apoptosis and Autophagy in Mice.
Ye J; Huang Y; Que B; Chang C; Liu W; Hu H; Liu L; Shi Y; Wang Y; Wang M; Zeng T; Zhen W; Xu Y; Shi L; Liu J; Jiang H; Ye D; Lin Y; Wan J; Ji Q
EBioMedicine; 2018 Sep; 35():29-39. PubMed ID: 30228093
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of Kininogen-1 aggravates oxidative stress and mitochondrial dysfunction in DOX-induced cardiotoxicity.
Cheng X; Liu D; Song H; Tian X; Yan C; Han Y
Biochem Biophys Res Commun; 2021 Apr; 550():142-150. PubMed ID: 33706097
[TBL] [Abstract][Full Text] [Related]
8. Multi-walled carbon nanotubes exacerbate doxorubicin-induced cardiotoxicity by altering gut microbiota and pulmonary and colonic macrophage phenotype in mice.
Liu X; Liu Y; Chen X; Wang C; Chen X; Liu W; Huang K; Chen H; Yang J
Toxicology; 2020 Apr; 435():152410. PubMed ID: 32068018
[TBL] [Abstract][Full Text] [Related]
9. C1qTNF-related protein 1 attenuates doxorubicin-induced cardiac injury via activation of AKT.
Chen H; Gao L; Huang Z; Liu Y; Guo S; Xing J; Meng Z; Liang C; Li Y; Yao R; Li L; Zhang Y; Gu H; Liu Y
Life Sci; 2018 Aug; 207():492-498. PubMed ID: 29964055
[TBL] [Abstract][Full Text] [Related]
10. Orosomucoid 1 Attenuates Doxorubicin-Induced Oxidative Stress and Apoptosis in Cardiomyocytes via Nrf2 Signaling.
Cheng X; Liu D; Xing R; Song H; Tian X; Yan C; Han Y
Biomed Res Int; 2020; 2020():5923572. PubMed ID: 33134382
[TBL] [Abstract][Full Text] [Related]
11. Promoting mitochondrial fusion in doxorubicin-induced cardiotoxicity: a novel therapeutic target for cardioprotection.
Maneechote C; Khuanjing T; Ongnok B; Arinno A; Prathumsap N; Chunchai T; Arunsak B; Nawara W; Chattipakorn SC; Chattipakorn N
Clin Sci (Lond); 2022 Jun; 136(11):841-860. PubMed ID: 35543245
[TBL] [Abstract][Full Text] [Related]
12. Protease-activated receptor 1 activation enhances doxorubicin-induced cardiotoxicity.
Antoniak S; Tatsumi K; Schmedes CM; Grover SP; Pawlinski R; Mackman N
J Mol Cell Cardiol; 2018 Sep; 122():80-87. PubMed ID: 30098988
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-22 deficiency alleviates doxorubicin-induced oxidative stress and cardiac injury via the p38 MAPK/macrophage/Fizz3 axis in mice.
Ye J; Wang Y; Xu Y; Wang Z; Liu L; Wang M; Ye D; Zhang J; Yang Z; Lin Y; Ji Q; Wan J
Redox Biol; 2020 Sep; 36():101636. PubMed ID: 32863209
[TBL] [Abstract][Full Text] [Related]
14. Asiatic Acid Protects against Doxorubicin-Induced Cardiotoxicity in Mice.
Hu X; Li B; Li L; Li B; Luo J; Shen B
Oxid Med Cell Longev; 2020; 2020():5347204. PubMed ID: 32509145
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of CACNA1H attenuates doxorubicin-induced acute cardiotoxicity by affecting endoplasmic reticulum stress.
Hu J; Wu Q; Wang Z; Hong J; Chen R; Li B; Hu Z; Hu X; Zhang M
Biomed Pharmacother; 2019 Dec; 120():109475. PubMed ID: 31580970
[TBL] [Abstract][Full Text] [Related]
16. FNDC5 alleviates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via activating AKT.
Zhang X; Hu C; Kong CY; Song P; Wu HM; Xu SC; Yuan YP; Deng W; Ma ZG; Tang QZ
Cell Death Differ; 2020 Feb; 27(2):540-555. PubMed ID: 31209361
[TBL] [Abstract][Full Text] [Related]
17. Sirt6 protects cardiomyocytes against doxorubicin-induced cardiotoxicity by inhibiting P53/Fas-dependent cell death and augmenting endogenous antioxidant defense mechanisms.
Wu S; Lan J; Li L; Wang X; Tong M; Fu L; Zhang Y; Xu J; Chen X; Chen H; Li R; Wu Y; Xin J; Yan X; Li H; Xue K; Li X; Zhuo C; Jiang W
Cell Biol Toxicol; 2023 Feb; 39(1):237-258. PubMed ID: 34713381
[TBL] [Abstract][Full Text] [Related]
18. IL-27p28 knockout aggravates Doxorubicin-induced cardiotoxicity by regulating Macrophage polarization.
Feng Y; Ji Q; Ye D; Pan H; Lu X; Gan L; Wang M; Liu J; Xu Y; Zhang J; Zhao M; Xu S; Yin Z; Pan W; Wei C; Liu M; Wan J; Ye J
Biochem Pharmacol; 2023 Apr; 210():115469. PubMed ID: 36868324
[TBL] [Abstract][Full Text] [Related]
19. Everolimus prevents doxorubicin-induced apoptosis in H9c2 cardiomyocytes but not in MCF-7 cancer cells: Cardioprotective roles of autophagy, mitophagy, and AKT.
Kanno SI; Hara A
Toxicol In Vitro; 2023 Dec; 93():105698. PubMed ID: 37739323
[TBL] [Abstract][Full Text] [Related]
20. Doxorubicin triggers bioenergetic failure and p53 activation in mouse stem cell-derived cardiomyocytes.
Cunha-Oliveira T; Ferreira LL; Coelho AR; Deus CM; Oliveira PJ
Toxicol Appl Pharmacol; 2018 Jun; 348():1-13. PubMed ID: 29653124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
